Drug Profile
Research programme: coronavirus and infectious disease therapeutics - Mannin Research/Q BioMed
Latest Information Update: 28 Mar 2024
Price :
$50
*
At a glance
- Originator Mannin Research
- Class Anti-infectives; Antivirals; Small molecules
- Mechanism of Action TIE-2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported COVID 2019 infections; Infections
Most Recent Events
- 28 Mar 2024 No recent reports of development identified for research development in COVID-2019-infections in Canada
- 28 Mar 2024 No recent reports of development identified for research development in COVID-2019-infections in USA
- 28 Mar 2024 No recent reports of development identified for research development in Infections in Canada